Brightsurf Science News & Current Events

December 04, 2010
Phase I trial indicates ponatinib may thwart most resistant CML
A new drug appears to help chronic myeloid leukemia patients who are out of treatment options after first- and second-line drugs have failed them or because their cancer cells have a mutation that makes them resistant from the start, researchers reported at the 52nd Annual Meeting of the American Society of Hematology.

Studies examine risk factor prediction and treatment regimens for venous thromboembolism
The latest advances in the treatment of bleeding and clotting disorders will be presented today at the 52nd Annual Meeting of the American Society of Hematology, focusing on venous thrombeombolism (VTE), a potentially life-threatening disorder in which abnormal blood clots form in the veins and restrict the flow of blood.

New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies.

UIC researcher unveils new approach to blocking malaria transmission
University of Illinois at Chicago researcher Dr. John Quigley unveils a new approach to blocking malaria transmission during the American Society of Hematology's annual meeting in Orlando, Fla.

Studies investigate pediatric sickle cell disease and potential breakthrough in controlling malaria
Research will be presented today at the 52nd Annual Meeting of the American Society of Hematology that highlights studies on transfusion therapy alternatives and genetic predictors for sickle cell-related stroke in children, the use of hydroxyurea therapy to reduce mortality in pediatric SCD patients, and a potential breakthrough that may inhibit the transmission of malaria causing viruses.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.